期刊文献+

局部运用阿仑磷酸钠对兔人工假体无菌性松动抑制作用的研究 被引量:6

Study of The Local Application of Alendronate on Inhibiting Aseptic Loosening of Prosthesis in Rabbits
下载PDF
导出
摘要 目的 探讨局部运用阿仑磷酸钠对抑制破骨细胞性骨吸收的影响,为临床上人工关节的松动提供预防和治疗的方法。方法 用20只大耳白兔建立骨质疏松模型后,在模型兔右侧股骨中上段截骨,用仿锤形不锈钢假体连接断端,一组用阿仑磷酸钠加骨水泥(PMMA)固定假体,对照组为单用PMMA固定。8周后处死全部实验兔,取出实验股骨,作生物力学实验和病理形态学检查,进行图像分析和统计学处理。结果 在拔出实验和扭转实验,阿仑磷酸钠组均显著优于对照组(P<0.01)。病理组织形态学检查阿仑磷酸钠组骨小梁体积比、厚度和数目高于对照组(P<0.01或P<0.05)。结论局部运用阿仑磷酸钠对人工假体无菌性松动有明显抑制作用,增加了人工假体的稳定性。 Objective To investigate the practical effect of the local application of alendronate on inhibiting osteolysis caused by osteoclast and provide the clinical methed of prevention and treatment on aseptic loosening of prosthesis.Methods Animal osteoporosis models were established in 20 rabbits, After osteotomy in right femur were operated, the stainless steel implants were implanted. 20 model rabbits were divided into 2 groups, with one group receiving alendronate PMMA bond, and the other group receiving PMMA bond as control. 20 rabbits were sacrificed after 8 weeks of implantation, Specimens of right femur were sectioned to be studied by biomechanical test and histomorphometry study. Results The pull-out strength and torsion moment of alendronate-PMMA group were significantly higher than that of control group(P<0.01). trabcular area percent, the thickness and the number of trabeculae were higher than that of control group(P<0.01 or P<0.05). Conclusion The local application of alendronate can inhibit aseptic loosening of prosthesis potently as a potent inhibitor of bone resorption and increase the stabilities of prosthesis in rabbit.
出处 《生物骨科材料与临床研究》 CAS 2003年第1期9-10,16,共3页 Orthopaedic Biomechanics Materials and Clinical Study
关键词 阿仑磷酸钠 破骨细胞 骨吸收 人工关节 Alendronate Osteoclast: Bone resorption Prosthesis
  • 相关文献

参考文献8

  • 1戚孟春,周秀青.雌激素对破骨细胞调节的细胞及分子机理[J].中国骨质疏松杂志,2002,8(3):278-280. 被引量:15
  • 2[2]Lin JH, Russell G, Gertz B. Pharmacokinetics of alendronate: an overview. Int J Clin Pract Suppl 1999 A pr; 101:18-26.
  • 3[3]Ohta T, Komatsu S, Tokutake N. Pharmacological and clinical properties of alendronate sodium hydrate. Nippon Yakurigaku Zasshi,2002 Dec; 120(6):409-19.
  • 4[4]Rodan GA, Reszka AA. Bisphosphonate mechanism of action. Curr Mol Med 2002 .Sep;2(6):571-7.
  • 5[5]Ito M, Amizuka N, Nakajima T,et al. Ultrastructural and cytochemical studies on cell death of osteoclasts induced by bisphosphonate treatment. Bone, 1999,25:447-452.
  • 6路景涛,杨雁,王斌,周爱武,陈敏珠.阿仑磷酸钠对体外破骨细胞性骨吸收影响的研究[J].中国药理学通报,2001,17(3):348-350. 被引量:3
  • 7[7]Shabokbar A, Fujikawa Y, Athanasou NA, Murray DW.Bisphosphonates in bone cement inhibit particle-induced bone resorption. Aun Rheum Dis, 1998,57: 614-618.
  • 8[8]Meraw S J, Reeve CM. Qualitative analysis of peripheral periimplated bone and influence of alendronate sodium on early bone regeneration. J Periodontol. 1999 Oct:70(10): 1228-33.

二级参考文献7

共引文献16

同被引文献75

  • 1黄连芳,李青南,林柏云,陈艳,胡彬.阿仑膦酸钠对大鼠松质骨和密质骨影响的比较[J].中国临床康复,2004,8(15):2892-2893. 被引量:3
  • 2廖晖,李锋,陈安民.载阿仑膦酸钠骨水泥抑制骨水泥微粒诱导的骨吸收[J].华中科技大学学报(医学版),2004,33(5):612-614. 被引量:2
  • 3蔡迅梓,严世贵,戴雪松.全膝置换术后应力遮挡致骨量丢失的研究进展[J].中华外科杂志,2006,44(20):1434-1436. 被引量:8
  • 4汪玉海,刘兴炎,白孟海,葛宝丰,陈克明,吕明波.骨形态发生蛋白对去势大鼠股骨颈骨形态、骨密度和骨生物力学的影响[J].中国组织工程研究与临床康复,2007,11(27):5273-5276. 被引量:6
  • 5GRUEN TA, MCNEICE GM, AMSTUTZ HC."Modes of failure" of cemented stem-type femoral components, a radiographic analysis of loosening[J]. Clin Orthop Relat Res, 1979, (141) : 17-27.
  • 6FENDER D, HARPER WM, GREGG PJ. Outcome of Charnley total hip replacement across a single health region in England:the results at five years frome a regional hip register [J]. J Bone Joint Surg Br, 1999, 81(4): 557-581.
  • 7DEVOGELAER JP, BROLL H, CORREA-ROTYER R, et al. Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis[J]. Bone, 1996, 18(2) : 141-150.
  • 8VENESMAA PK, KROGER HP, MIEITNEN HJ, et al. Mendronate reduces periprosthetic bone loss after uneemented primary total hip arthroplasty: a prospective randomized study[J]. J Bone Miner Res, 2001, 16(11) : 2126-2131.
  • 9HENNIGS T, ARABMOTLAGH M, SCHWARZ A, et al. Dosedependent prevention of early periprosthetie bone loss by alendronate[J]. Z Orthop Ihre Grenzgeb, 2002, 140(1 ): 42-47.
  • 10NEHME A, MAALOUF G, TRICOIRE JL, et al. Effect of alendronate on periprosthetic bone loss after cemented primary total hip arthroplasty: a prospective randomized study [J]. Rev Chir Orthop Reparatrice Appar Mot, 2003, 89(7):593-598.

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部